Concepedia

Author

Paolo Anderlini

The University of Texas MD Anderson Cancer Center

Also Known As

Muzaffar Qazilbash, P Anderlini, P. Anderlini, PAOLO ANDERLINI, Paolo Anderlini, Paolo N. Anderlini, Pulsipher, Michael A.

398

Publications

16.6K

Citations

62

H-Index

64

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterMedical College of WisconsinNational Marrow Donor ProgramFred Hutch Cancer CenterThe University of Texas Health Science Center at Houston
PA

About

Paolo Anderlini is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

33

58

3.7K

2

Health Sciences

21

22

1.2K

3

Blood Transplantation

19

19

1.2K

4

Cellular Therapies

15

15

909

5

Cell Biology

5

5

275

Paolo Anderlini

×

158

Publications

15K

Citations

59

H-Index

YearCitations

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Sergio Giralt, Elihu H. Estey, Maher Albitar,

Blood

1997

1.2K

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling,

Journal of Clinical Oncology

1998

927

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Claudio Anasetti, Brent R. Logan, Stephanie J. Lee,

New England Journal of Medicine

2012

882

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri,

Blood

2001

570

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri,

Blood

2001

516

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

Issa F. Khouri, Rima M. Saliba, Sergio Giralt,

Blood

2001

363

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

Issa F. Khouri, Peter McLaughlin, Rima M. Saliba,

Blood

2008

293

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD

Daniel R. Couriel, Chitra Hosing, Rima M. Saliba,

Blood

2005

270

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

Michael A. Pulsipher, Pintip Chitphakdithai, J. Philip Miller,

Blood

2009

263

Tumor necrosis factor-α blockade for the treatment of acute GVHD

Daniel R. Couriel, Rima M. Saliba, Krystal Hicks,

Blood

2004

260

Page 1